{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:40:05Z","timestamp":1781365205564,"version":"3.54.1"},"reference-count":41,"publisher":"MathDoc\/Centre Mersenne","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    This work investigates whether the two 1,5-benzodiazepine compounds: 4-(2-hydroxyphenyl)-1,5-benzodiazepin-2-one (RG0501) and Benzopyrano [4,3-c] 1,5-benzodiazepine (RG0502) have any neuropharmacological activities. Diazepam and Flunitrazepam were used as drug references. The investigational 1,5-BDZ were tested in vivo for potentiating hexobarbital-induced sleep and pentylenetetrazole (PTZ)-induced seizures. Our study demonstrated that the increase of sleep duration was significantly higher with RG0501 as compared to RG0502. However, RG0502 anticonvulsant effect was more pronounced than that of RG0501 in the range dose of 6.25-37.5\u2005mg.kg\n                    <jats:sup>-1<\/jats:sup>\n                    . From the 50\u2005mg.kg\n                    <jats:sup>-1<\/jats:sup>\n                    dose, RG0502 offered a protection against clonic-tonic seizures as well as lethality (\n                    <jats:italic>p<\/jats:italic>\n                    \u2005\u2264\u20050.05). The results showed that the required doses to obtain a pharmacological activity were more than those of the references. This difference could be related to the lack of specific substituants responsible for the pharmacological activity in the tested compounds.\n                  <\/jats:p>","DOI":"10.1016\/j.crvi.2009.09.015","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T04:41:57Z","timestamp":1267764117000},"page":"214-219","source":"Crossref","is-referenced-by-count":24,"title":["Neuropharmacological screening of two 1,5-benzodiazepine compounds in mice"],"prefix":"10.5802","volume":"333","author":[{"given":"Wafa","family":"Ben-Cherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hichem","family":"Sebai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorra","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naceur A.","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mossadok","family":"Ben-Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3842","published-online":{"date-parts":[[2010,3,1]]},"reference":[{"key":"key2025102316330553391_1","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0022-3565(24)36923-X","article-title":"Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative\/anxiolytics","volume":"282","author":"Ator, N.A.","year":"1997","unstructured":"[1] Ator, N.A.; Griffiths, R.R. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative\/anxiolytics, J. Pharmacol. Exp. Ther., Volume 282 (1997), pp. 1442-1457","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key2025102316330553391_2","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1039\/b303995c","article-title":"1,3-Dipolar cycloaddition of nitrilimines to 2,4-disubstituted-3H-1,5-benzodiazepines: remarkable effect of C4-substituent on diastereoselectivity","volume":"27","author":"Nabih, K.","year":"2003","unstructured":"[2] Nabih, K.; Baouid, A.; Hasnaoui, A.; Selkti, M.; Compain, P. 1,3-Dipolar cycloaddition of nitrilimines to 2,4-disubstituted-3H-1,5-benzodiazepines: remarkable effect of C4-substituent on diastereoselectivity, New J. Chem., Volume 27 (2003), pp. 1644-1648","journal-title":"New J. Chem."},{"key":"key2025102316330553391_3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ejmech.2005.06.008","article-title":"Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs","volume":"40","author":"Falc\u00f3, J.L.","year":"2005","unstructured":"[3] Falc\u00f3, J.L.; Lloveras, M.; Buira, I.; Teixid\u00f3, J.; Borrell, J.I.; M\u00e9ndez, E.; Terencio, J.; Palomer, A.; Guglietta, A. Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs, Eur. J. Med. Chem., Volume 40 (2005), pp. 1179-1187","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000028247","article-title":"Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action","volume":"57","author":"Fukinaga, M.","year":"1998","unstructured":"[4] Fukinaga, M.; Ishizawa, K.; Kamei, C. Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action, Pharmacology, Volume 57 (1998), pp. 233-241","journal-title":"Pharmacology"},{"key":"key2025102316330553391_5","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2174\/1381612054021024","article-title":"GABA<sub>A<\/sub> Receptor channel pharmacology","volume":"11","author":"Johnston, G.A.","year":"2005","unstructured":"[5] Johnston, G.A. GABAA Receptor channel pharmacology, Curr. Pharm. Des., Volume 11 (2005), pp. 1867-1885","journal-title":"Curr. Pharm. Des."},{"key":"key2025102316330553391_6","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm00171a047","article-title":"Tricyclic heteroaromatic systems. [1] benzopyranopyrrol-4-ones and [1] benzopyrano-1,2,3-triazol-4-ones as benzodiazepine receptor ligands. Synthesis and structure-activity relationships","volume":"33","author":"Colotta, V.","year":"1990","unstructured":"[6] Colotta, V.; Cecchi, L.; Melani, F.; Filacchioni, G.; Martini, C.; Giannaccini, G.; Lucacchini, A. Tricyclic heteroaromatic systems. [1] benzopyranopyrrol-4-ones and [1] benzopyrano-1,2,3-triazol-4-ones as benzodiazepine receptor ligands. Synthesis and structure-activity relationships, J. Med. Chem., Volume 33 (1990), pp. 2646-2651","journal-title":"J. Med. Chem."},{"key":"key2025102316330553391_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1383\/psyt.3.4.11.32907","article-title":"Psychopharmacology of anxiety","volume":"3","author":"Nash, J.","year":"2004","unstructured":"[7] Nash, J.; Nutt, D.J. Psychopharmacology of anxiety, Psychiatry, Volume 3 (2004), pp. 11-15","journal-title":"Psychiatry"},{"key":"key2025102316330553391_8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm0509400","article-title":"Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABA<sub>A<\/sub> receptors","volume":"49","author":"Grunwald, C.","year":"2006","unstructured":"[8] Grunwald, C.; Rundfeldt, C.; Lankau, H.J.; Arnold, T.; H\u00f6fgen, N.; Dost, R.; Egerland, U.; Hofmann, H.J.; Unverferth, K. Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors, J. Med. Chem., Volume 49 (2006), pp. 1855-1866","journal-title":"J. Med. Chem."},{"key":"key2025102316330553391_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.npep.2007.05.001","article-title":"Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon","volume":"41","author":"Rajarao, S.J.","year":"2007","unstructured":"[9] Rajarao, S.J.; Platt, B.; Sukoff, S.J.; Lin, Q.; Bender, C.N.; Nieuwenhuijsen, B.W.; Ring, R.H.; Schechter, L.E.; Rosenzweig-Lipson, S.; Beyer, C.E. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon, Neuropeptides, Volume 41 (2007), pp. 307-320","journal-title":"Neuropeptides"},{"key":"key2025102316330553391_10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.physbeh.2006.09.006","article-title":"The sleep-wake cycle and sleeping pills","volume":"90","author":"Lemmer, B.","year":"2007","unstructured":"[10] Lemmer, B. The sleep-wake cycle and sleeping pills, Physiol. Behav., Volume 90 (2007), pp. 285-293","journal-title":"Physiol. Behav."},{"key":"key2025102316330553391_11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bmc.2005.08.058","article-title":"Benzodiazepine receptor ligands. 8: Synthesis and pharmacological evaluation of new pyrazolo [5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy","volume":"14","author":"Guerrini, G.","year":"2006","unstructured":"[11] Guerrini, G.; Costanzo, A.; Ciciani, G.; Bruni, F.; Selleri, S.; Costagli, C.; Besnard, F.; Costa, B.; Martini, C.; De Siena, G.; Malmberg-Aiello, P. Benzodiazepine receptor ligands. 8: Synthesis and pharmacological evaluation of new pyrazolo [5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy, Bioorg. Med. Chem., Volume 14 (2006), pp. 758-775","journal-title":"Bioorg. Med. Chem."},{"key":"key2025102316330553391_12","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1523\/JNEUROSCI.17-10-03467.1997","article-title":"Silent GABA<sub>A<\/sub> synapses during flurazepam withdrawal are region-specific in the hippocampal formation","volume":"17","author":"Poisbeau, P.","year":"1997","unstructured":"[12] Poisbeau, P.; Williams, S.R.; Mody, I. Silent GABAA synapses during flurazepam withdrawal are region-specific in the hippocampal formation, J. Neurosci., Volume 17 (1997), pp. 3467-3475","journal-title":"J. Neurosci."},{"key":"key2025102316330553391_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/NP.2005.289","article-title":"Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes","volume":"12","author":"Savi\u0107, M.M.","year":"2005","unstructured":"[13] Savi\u0107, M.M.; Obradovi\u0107, D.I.; Ugresi\u0107, N.D.; Bokonji\u0107, D.R. Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes, Neural Plast., Volume 12 (2005), pp. 289-298","journal-title":"Neural Plast."},{"key":"key2025102316330553391_14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.04.049","article-title":"Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice","volume":"541","author":"Weso\u0142owska, A.","year":"2006","unstructured":"[14] Weso\u0142owska, A.; Nikiforuk, A.; Chojnacka-W\u00f3jcik, E. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice, Eur. J. Pharmacol., Volume 541 (2006), pp. 57-63","journal-title":"Eur. J. Pharmacol."},{"key":"key2025102316330553391_15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The combinatorial synthesis of bicyclic privileged structures or privileged substructures","volume":"103","author":"Horton, D.A.","year":"2003","unstructured":"[15] Horton, D.A.; Bourne, G.T.; Smythe, M.L. The combinatorial synthesis of bicyclic privileged structures or privileged substructures, Chem. Rev., Volume 103 (2003), pp. 893-930","journal-title":"Chem. Rev."},{"key":"key2025102316330553391_16","first-page":"519","article-title":"Effect of a derivative of 1,5-benzodiazepine on sleep","volume":"126","author":"Ayala-Guerrero, F.","year":"1990","unstructured":"[16] Ayala-Guerrero, F.; Vargas-Reyna, L.; Taboada, J.; Mart\u03afnez, R.; Cort\u00e9s, E. Effect of a derivative of 1,5-benzodiazepine on sleep, Gac. Med. Mex., Volume 126 (1990), pp. 519-522","journal-title":"Gac. Med. Mex."},{"key":"key2025102316330553391_17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1107\/S0108270199014754","article-title":"8-Chloro-6-phenyl-4H-[1,2,4]-triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one","volume":"56","author":"Borassi, A.","year":"2000","unstructured":"[17] Borassi, A.; Carnasciali, M.M.; Mugnoli, A.; Roma, G. 8-Chloro-6-phenyl-4H-[1,2,4]-triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one, Acta Crystallogr. C., Volume 56 (2000), pp. 258-259","journal-title":"Acta Crystallogr. C."},{"key":"key2025102316330553391_18","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1021\/jm00067a009","article-title":"New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study","volume":"36","author":"Li\u00e9geois, J.F.","year":"1993","unstructured":"[18] Li\u00e9geois, J.F.; Bruhwyler, J.; Damas, J.; Nguyen, T.P.; Chleide, E.M.; Mercier, M.G.; Rogister, F.A.; Delarge, J.E. New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study, J. Med. Chem., Volume 36 (1993), pp. 2107-2114","journal-title":"J. Med. Chem."},{"key":"key2025102316330553391_19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.farmac.2004.12.005","article-title":"1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3\u2032,4\u2032-d] [1,5]benzodiazepines and related compounds endowed with in vitro cytotoxic properties","volume":"60","author":"Di Braccio, M.","year":"2005","unstructured":"[19] Di Braccio, M.; Grossi, G.; Ceruti, M.; Rocco, F.; Loddo, R.; Sanna, G.; Busonera, B.; Murreddu, M.; Marongiu, M.E. 1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3\u2032,4\u2032-d] [1,5]benzodiazepines and related compounds endowed with in vitro cytotoxic properties, Farmaco., Volume 60 (2005), pp. 113-125","journal-title":"Farmaco."},{"key":"key2025102316330553391_20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0223-5234(90)90133-N","article-title":"1,5-Benzodiazepines VIII. Novel 4H-[1,2,4] triazolo[4,3-a][1,5]benzodiazepine derivatives with analgesic or anti-inflammatory activity","volume":"25","author":"Di Braccio, M.","year":"1990","unstructured":"[20] Di Braccio, M.; Roma, G.; Grossi, G.C.; Ghia, M.; Mereto, E. 1,5-Benzodiazepines VIII. Novel 4H-[1,2,4] triazolo[4,3-a][1,5]benzodiazepine derivatives with analgesic or anti-inflammatory activity, Eur. J. Med. Chem., Volume 25 (1990), pp. 681-687","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/phrs.2001.0800","article-title":"1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE<sub>2<\/sub> production","volume":"43","author":"Fruscella, P.","year":"2001","unstructured":"[21] Fruscella, P.; Sottocorno, M.; Di Braccio, M.; Diomede, L.; Piccardi, N.; Cagnotto, A.; Grossi, G.; Romano, M.; Mennini, T.; Roma, G. 1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE2 production, Pharmacol. Res., Volume 43 (2001), pp. 445-452","journal-title":"Pharmacol. Res."},{"key":"key2025102316330553391_22","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejmech.2007.08.007","article-title":"Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins","volume":"43","author":"Kalkhambkar, R.G.","year":"2008","unstructured":"[22] Kalkhambkar, R.G.; Kulkarni, G.M.; Kamanavalli, C.M.; Premkumar, N.; Asdaq, S.M.; Sun, C.M. Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins, Eur. J. Med. Chem., Volume 43 (2008), pp. 2178-2188","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jhet.5570290723","article-title":"Synthesis of N-substituted \u03b1-aminoacids from 4-hydroxycoumarin","volume":"29","author":"Hamdi, M.","year":"1992","unstructured":"[23] Hamdi, M.; Sakellariou, R.; Speziale, V. Synthesis of N-substituted \u03b1-aminoacids from 4-hydroxycoumarin, J Heterocycl. Chem., Volume 29 (1992), pp. 1817-1819","journal-title":"J Heterocycl. Chem."},{"key":"key2025102316330553391_24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1515\/HC.2002.8.4.335","article-title":"Synthesis of new fused benzopyrano-benzodiazepinones","volume":"8","author":"Gharbi, R.","year":"2002","unstructured":"[24] Gharbi, R.; Trim\u00e8che, B.; Mighri, Z.; Martin, M.T. Synthesis of new fused benzopyrano-benzodiazepinones, Heterocycl. Commun., Volume 8 (2002), pp. 335-338","journal-title":"Heterocycl. Commun."},{"key":"key2025102316330553391_25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/bja\/55.10.985","article-title":"In vitro quantitation of benzodiazepine lipophilicity: Relation to in vivo distribution","volume":"55","author":"Greenblatt, D.J.","year":"1983","unstructured":"[25] Greenblatt, D.J.; Arendt, R.M.; Abernethy, D.R.; Giles, H.G.; Sellers, E.M.; Shader, R.I. In vitro quantitation of benzodiazepine lipophilicity: Relation to in vivo distribution, Brit. J. Anaesth., Volume 55 (1983), pp. 985-989","journal-title":"Brit. J. Anaesth."},{"key":"key2025102316330553391_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eplepsyres.2004.10.001","article-title":"Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice","volume":"63","author":"Sayyah, M.","year":"2005","unstructured":"[26] Sayyah, M.; Yousefi-Pour, M.; Narenjkar, J. Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice, Epilepsy Res., Volume 63 (2005), pp. 11-16","journal-title":"Epilepsy Res."},{"key":"key2025102316330553391_27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tox.2004.03.017","article-title":"Effects of endosulfan on B cells of Langerhans islets in rat pancreas","volume":"200","author":"Kalender, Y.","year":"2004","unstructured":"[27] Kalender, Y.; Kalender, S.; Uzunhisarcikli, M.; Ogutcu, A.; A\u00e7ikgoz, F.; Durak, D. Effects of endosulfan on B cells of Langerhans islets in rat pancreas, Toxicology, Volume 200 (2004), pp. 205-211","journal-title":"Toxicology"},{"key":"key2025102316330553391_28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bmc.2005.08.042","article-title":"Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile","volume":"14","author":"Menegatti, R.","year":"2006","unstructured":"[28] Menegatti, R.; Silva, G.M.; Zapata-Sudo, G.; Raimundo, J.M.; Sudo, R.T.; Barreiro, E.J.; Fraga, C.A. Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile, Bioorgan. Med. Chem., Volume 14 (2006), pp. 632-640","journal-title":"Bioorgan. Med. Chem."},{"key":"key2025102316330553391_29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/1043-6618(94)80001-4","article-title":"Effects of chloroquine on pentylenetetrazol-induced convulsions in mice","volume":"30","author":"N\u2019Gouemo, P.","year":"1994","unstructured":"[29] N\u2019Gouemo, P.; Ben Attia, M.; Belaidi, M. Effects of chloroquine on pentylenetetrazol-induced convulsions in mice, Pharmacol. Res., Volume 30 (1994), pp. 99-103","journal-title":"Pharmacol. Res."},{"key":"key2025102316330553391_30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejmech.2006.12.022","article-title":"New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity","volume":"42","author":"Lankau, H.J.","year":"2007","unstructured":"[30] Lankau, H.J.; Unverferth, K.; Grunwald, C.; Hartenhauer, H.; Heinecke, K.; Bern\u00f6ster, K.; Dost, R.; Egerland, U.; Rundfeldt, C. New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity, Eur. J. Med. Chem., Volume 42 (2007), pp. 873-879","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_31","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1021\/jm00130a025","article-title":"Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido [2,3 b] [1,5] benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity","volume":"32","author":"Chakrabarti, J.K.","year":"1989","unstructured":"[31] Chakrabarti, J.K.; Hotten, T.M.; Pullar, I.A.; Steggles, D.J. Synthesis and pharmacological evaluation of CNS activities of [1,2,3]triazolo[4,5-b][1,5]-, imidazolo[4,5-b][1,5]-, and pyrido [2,3 b] [1,5] benzodiazepines. 10-Piperazinyl-4H-1,2,3-triazolo[4,5-b][1,5]benzodiazepines with neuroleptic activity, J. Med. Chem., Volume 32 (1989), pp. 2375-2381","journal-title":"J. Med. Chem."},{"key":"key2025102316330553391_32","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/jm00132a012","article-title":"Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics","volume":"32","author":"Chakrabarti, J.K.","year":"1989","unstructured":"[32] Chakrabarti, J.K.; Hotten, T.M.; Pullar, I.A.; Type, N.C. Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics, J. Med. Chem., Volume 32 (1989), pp. 2573-2582","journal-title":"J. Med. Chem."},{"key":"key2025102316330553391_33","unstructured":"[33] El Haddar S, Jarmoumi C, Bakri Y, Essassi EM, Martin P, Massoui M, Benjouad A, \u00c9valuation des propri\u00e9t\u00e9s anticanc\u00e9reuses de nouvelles glycomol\u00e9cules d\u00e9riv\u00e9es de benzodiaz\u00e9pines, International Congress of Biochemistry, Agadir, Morocco, May 09\u201312 (2006) 275\u2013277."},{"key":"key2025102316330553391_34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0223-5234(93)90088-V","article-title":"1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substitued 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity","volume":"28","author":"Grossi, G.C.","year":"1993","unstructured":"[34] Grossi, G.C.; Di Braccio, M.; Roma, G.; Ghia, M.; Brambilla, G. 1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substitued 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity, Eur. J. Med. Chem., Volume 28 (1993), pp. 577-584","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_35","first-page":"474","article-title":"Crystal structure of N,N-dimethyl-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]-benzodiazepin-5-amine, C<sub>18<\/sub>H<sub>17<\/sub>N<sub>5<\/sub>","volume":"216","author":"Borassi, A.","year":"2001","unstructured":"[35] Borassi, A.; Di Braccio, M.; Grossi, G.C.; Izzo, G.; Mugnoli, A. Crystal structure of N,N-dimethyl-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]-benzodiazepin-5-amine, C18H17N5, Z. Kristallogr., Volume 216 (2001), pp. 474-476","journal-title":"Z. Kristallogr."},{"key":"key2025102316330553391_36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0223-5234(02)01400-9","article-title":"1,5-Benzodiazepines: Part XIII. Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine-5-amines and 4H-imidazo[1,2-a][1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and\/or antipyretic agents with low acute toxicity","volume":"37","author":"Grossi, G.C.","year":"2002","unstructured":"[36] Grossi, G.C.; Di Braccio, M.; Roma, G.; Ballabeni, V.; Tognolini, M.; Calcina, F.; Barocelli, E. 1,5-Benzodiazepines: Part XIII. Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine-5-amines and 4H-imidazo[1,2-a][1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and\/or antipyretic agents with low acute toxicity, Eur. J. Med. Chem., Volume 37 (2002), pp. 933-944","journal-title":"Eur. J. Med. Chem."},{"key":"key2025102316330553391_37","first-page":"645","article-title":"Synthesis and pharmacologic study of 1,5-dialkyl-1,5-benzodiazepine-2,4-dithiones","volume":"54","author":"Zellou, A.","year":"1999","unstructured":"[37] Zellou, A.; Keita, A.; Cherrah, Y.; Essassi, E.M.; Hassar, M. Synthesis and pharmacologic study of 1,5-dialkyl-1,5-benzodiazepine-2,4-dithiones, Therapie, Volume 54 (1999), pp. 645-649","journal-title":"Therapie"},{"key":"key2025102316330553391_38","first-page":"225","article-title":"Meta-analysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook, A.M.","year":"2000","unstructured":"[38] Holbrook, A.M.; Crowther, R.; Lotter, A.; Cheng, C.; King, D. Meta-analysis of benzodiazepine use in the treatment of insomnia, CMAJ, Volume 162 (2000), pp. 225-233","journal-title":"CMAJ"},{"key":"key2025102316330553391_39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1289\/ehp.8561295","article-title":"Development of quantitative structure-pharmacokinetic relationships","volume":"61","author":"Mayer, J.M.","year":"1985","unstructured":"[39] Mayer, J.M.; van de Waterbeemd, H. Development of quantitative structure-pharmacokinetic relationships, Environ. Health. Perspect., Volume 61 (1985), pp. 295-306","journal-title":"Environ. Health. Perspect."},{"key":"key2025102316330553391_40","doi-asserted-by":"crossref","unstructured":"[40] GA Gu\u00e9rin, J Pratuangdejkul, M Alemany, JM Launay, P Manivet, Rational and efficient geometric definition of pharmacophores is essential for the patent process, Drug Discov. Today 11 (2006) 991\u2013998.","DOI":"10.1016\/j.drudis.2006.09.003"},{"key":"key2025102316330553391_41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-328X(01)00272-8","article-title":"Structural requirements of benzodiazepines for the inhibition of pig brain nitric oxide synthase","volume":"96","author":"Fern\u00e1ndez-Cancio, M.","year":"2001","unstructured":"[41] Fern\u00e1ndez-Cancio, M.; Fern\u00e1ndez-Vitos, E.M.; Imperial, S.; Centelles, J.J. Structural requirements of benzodiazepines for the inhibition of pig brain nitric oxide synthase, Mol. Brain Res., Volume 96 (2001), pp. 87-93","journal-title":"Mol. Brain Res."}],"container-title":["Comptes Rendus. Biologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/item\/10.1016\/j.crvi.2009.09.015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:42:19Z","timestamp":1761230539000},"score":1,"resource":{"primary":{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/articles\/10.1016\/j.crvi.2009.09.015\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,1]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010]]}},"alternative-id":["10.1016\/j.crvi.2009.09.015"],"URL":"https:\/\/doi.org\/10.1016\/j.crvi.2009.09.015","relation":{},"ISSN":["1631-0691","1768-3238"],"issn-type":[{"value":"1631-0691","type":"print"},{"value":"1768-3238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,1]]}}}